# UNIVERSITY OF CALIFORNIA LOS ANGELES: The development & pilot implementation of a CRISPR-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and molecular markers of antimicrobial resistance in resource-limited settings

**Lab Budget Score:** 25/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF CALIFORNIA LOS ANGELES |
| Location | LOS ANGELES, CA |
| Project | The development & pilot implementation of a CRISPR-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and molecular markers of antimicrobial resistance in resource-limited settings |
| Project number | 3K23AI182453-03S1 |
| Mechanism | K23 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $43,171 |
| Awarded | 2026-09-17 |
| Project period | 2026-08-01 to 2029-07-31 |
| UEI | RN64EPNH8JC6 |

## Why this score
- Award of $43,171.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11621917). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.